甲状腺疾病治疗市场预测至 2028 年——按疾病类型、给药途径、药物类别、药物类型、分销渠道和地区进行的全球分析

根据 Stratistics MRC 的数据，2022 年全球甲状腺疾病治疗市场规模将达到 272685 万美元，预计到 2028 年将达到 382451 万美元，预计复合年增长率为 5.8% .

甲状腺是一种内分泌腺，可促进有助于控制身体新陈代谢的激素分泌。 当甲状腺产生过多或过少的甲状腺激素时，它会干扰身体的新陈代谢和功能。 甲状腺疾病的主要原因之一是体内缺乏碘。 据信全世界有超过 20 亿人面临碘缺乏症的风险，其中一半被误诊。 此外，这些人中的大多数都没有被确诊，而且大多数都在欠发达国家。 功能或结构问题可导致甲状腺疾病。 据说妇女和老年人更容易感染这种疾病。

根据美国卫生与公共服务部公布的数据，美国每年约有 1.2% 的人患有甲状腺功能减退症。 此外，据说女性患甲状腺疾病的可能性是男性的 2 到 10 倍。

市场动态：

驱动程序

主持人：诊断和治疗技术的进步

甲状腺疾病治疗市场见证了诊断和治疗技术的多项进步，有助于改善患者的治疗效果和生活质量。 就诊断技术而言，超声是一种非侵入性成像技术，它使用声波来创建甲状腺图像。 它通常用于检测甲状腺结节，并有助于确定结节是癌性还是良性。 细针穿刺活检也是一种诊断程序，其中使用细针从甲状腺中取出和分析细胞。 诊断和治疗技术的进步将显着改善甲状腺疾病治疗市场，从而改善患者的治疗效果和生活质量，并在预测期内加速市场增长。

约束

副作用和并发症

如果不及时治疗或治疗不当，甲状腺疾病会导致多种并发症。 甲状腺疾病的治疗取决于疾病的类型和严重程度，但所有治疗都有副作用和并发症的风险。 甲状腺疾病有有效的治疗方法，但所有治疗方法都有副作用和并发症的风险。 必须与医疗保健专业人员密切合作以管理治疗并监测潜在的副作用和并发症，这预计会阻碍雾计算市场的增长。

机会

甲状腺疾病患病率增加

甲状腺疾病在世界范围内变得越来越普遍，影响了数百万人。 甲状腺疾病的患病率正在上升，有几个因素促成了这一趋势。 年龄是一个重要因素，患甲状腺疾病的风险会随着年龄的增长而增加。 女性也比男性更容易患甲状腺疾病。 辐射和接触某些化学物质等环境因素会增加患甲状腺疾病的风险。 此外，有甲状腺疾病家族史会增加患甲状腺疾病的风险。

威胁

严格的监管政策

甲状腺疾病治疗市场受到严格的监管政策的约束，以确保治疗的安全性和有效性。 这些政策由美国的食品和药物管理局 (FDA)、欧洲的欧洲药品管理局 (EMA) 以及世界其他国家的监管机构等监管机构实施。 甲状腺疾病治疗的监管政策包括临床前和临床试验的要求，以确定药物、医疗器械和其他治疗的安全性和有效性。 这些试验必须遵守严格的研究设计、患者招募和伦理考虑指南。 严格的监管政策对甲状腺治疗市场的公司构成挑战，但对于确保患者治疗的安全性和有效性至关重要。

COVID-19 的影响：

在 COVID 期间，大多数行业都受到了不利影响。 这是由于世界各地的政府机构实施的各种预防性封锁和其他限制措施已对其各自的生产和供应链运营造成巨大破坏。 全球治疗甲状腺疾病的药物市场也是如此。 此外，随着大多数人的总体经济状况受到此次疫情的严重影响，人们更愿意削减预算中的非必要支出，消费者需求正在下降。

甲亢段预计在预测期内最大

甲状腺功能亢进症是由甲状腺分泌过多甲状腺素引起的。 预计该领域在预测期内将有显着发展，部分原因是全球甲状腺癌和甲状腺功能亢进症的患病率上升。 StatPearls 发表于 2022 年 7 月的一篇文章发现，亚临床甲亢对 65 岁以上女性的影响多于男性，而明显甲亢的发生率为每 1000 名女性 0.4 例，每 1000 名男性 0.1 例，并且随年龄变化。 由于甲状腺功能亢进症的高患病率，预计会出现针对这种疾病的尖端疗法，这有望在预测期内推动市场扩张。

预计左旋甲状腺素在预测期内的复合年增长率最高。

对于甲状腺功能减退症的治疗，预计左旋甲状腺素在预测期内将保持最高的复合年增长率。 甲状腺功能减退症和甲状腺功能亢进症领域在用于治疗甲状腺问题的药物市场中占据主导地位。 左旋甲状腺素和碘塞罗宁是用于治疗甲状腺功能减退症的药物示例。 甲状腺疾病治疗市场的主要驱动因素是甲状腺疾病的全球患病率不断上升、新兴国家和发达国家对含左旋甲状腺素药物的需求不断增加，以及领先的甲状腺药物製造商创造了尖端疗法。我们正在以由于我们持续致力于

市场份额最高的地区：

北美在预期期间的收入份额最大。 该地区的高收入份额部分归因于高效医疗设施的存在、人们知识水平高以及可用治疗范围广泛。 该地区正在见证製药公司和政府机构之间的战略合作伙伴关係，特别是在仿製药的生产和提高医疗保健专业人员的意识方面。 正因如此，北美市场的利润颇丰。 例如，Genzyme 计划与 Veracyte 合作，为管理甲状腺问题提供个性化治疗。

复合年增长率最高的地区：

预计亚太地区在预测期内的增长率最快。 由于该地区甲状腺疾病的高患病率和不断增加的医疗支出，该地区的製造商正专注于开发成本更低、效率更高的产品。 受原材料和劳动力成本低廉的吸引，全球企业也在该地区投资当地公司。 此外，世界各地还举办了甲状腺宣传月，以提高人们对甲状腺相关疾病和甲状腺癌的认识。 这些努力有望促进早期发现和早期治疗，推动预测期内的市场增长。

主要发展：

2022 年 11 月：美国子公司 Zydus Lifesciences 获得美国联邦药物管理局 (USFDA) 的左旋甲状腺素钠注射液上市许可，用于治疗甲状腺激素缺乏症。

2022 年 5 月，美国食品和药物管理局 (FDA) 批准了礼来公司新的每週一次的 GIP（葡萄糖依赖性促胰岛素多□）和 GLP-1（胰高血糖素样□-1））批准的替西□注射液，一种受体激动剂，可作为饮食和运动的辅助手段，以改善成人 2 型糖尿病患者的血糖控制。

2021 年 9 月，Exelixis Inc. 宣布 CABOMETYX（卡博替尼）用于在先前针对血管内皮生长因子受体 (VEGFR) 的治疗后出现进展的局部晚期或转移性分化型甲状腺癌 (DTC)。获得 USFDA 批准用于治疗放射性碘-难治性或不合格的成人和儿童患者。

本报告内容

• 区域和国家级细分市场的市场份额评估
• 向新进入者提出战略建议
• 2020、2021、2022、2025 和 2028 年的综合市场数据
• 市场趋势（驱动因素、制约因素、机会、威胁、挑战、投资机会、建议）
• 根据市场预测在关键业务领域提出战略建议
• 竞争格局映射关键共同趋势。
• 公司简介，包括详细的战略、财务状况和近期发展
• 映射最新技术进步的供应链趋势

免费定制优惠：

购买此报告的客户将获得以下免费定制选项之一：

• 公司简介
  • 其他市场参与者的综合概况（最多 3 家公司）
  • 主要参与者的 SWOT 分析（最多 3 家公司）
• 区域细分
  • 根据客户的要求对主要国家/地区的市场估计/预测/复合年增长率（注意：基于可行性检查）。
• 竞争基准
  • 根据产品组合、区域影响力和战略联盟对主要参与者进行基准测试

内容

第 1 章执行摘要

第二章前言

• 概览
• 利益相关者
• 调查范围
• 调查方法
  • 数据挖掘
  • 数据分析
  • 数据验证
  • 研究方法
• 调查来源
  • 主要研究来源
  • 二级研究来源
  • 假设

第三章市场趋势分析

• 司机
• 约束因素
• 机会
• 威胁
• 新兴市场
• COVID-19 的影响

第 4 章波特五力分析

• 供应商的议价能力
• 买家的议价能力
• 替代品的威胁
• 新进入者的威胁
• 竞争公司之间的敌对关係

第 5 章全球甲状腺疾病治疗市场：按疾病类型分类

• 甲减
• 甲亢
• 其他

第 6 章全球甲状腺疾病治疗市场：按给药途径

• 口语
• 肠外
• 静脉注射
• 其他

第7章 全球甲状腺疾病治疗市场：按药物分类

• 硫代□胺
• 离子抑製剂
• 激素释放抑製剂
• 其他

第 8 章全球甲状腺疾病治疗市场：按药物类型分类

• 左旋甲状腺素
• 碘塞罗宁
• 丙基硫氧嘧啶
• 咪唑化合物
• 其他

第 9 章。全球甲状腺疾病治疗市场：按分销渠道

• 批发分销
• 零售店
• 在线药店
• 邮购药房
• 其他分销渠道

第 10 章全球甲状腺疾病治疗市场：按地区

• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 意大利
  • 法国
  • 西班牙
  • 其他欧洲
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳大利亚
  • 新西兰
  • 韩国
  • 其他亚太地区
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 其他南美洲
• 中东和非洲
  • 沙特阿拉伯
  • 阿拉伯联合酋长国
  • 卡塔尔
  • 南非
  • 其他中东和非洲地区

第11章主要发展

• 合同、伙伴关係、协作和合资企业
• 收购与合併
• 新产品发布
• 业务扩展
• 其他关键策略

第十二章公司简介

• Abbott Laboratories
• AbbVie Inc.
• ALLERGAN
• Alvogen ehf
• Amgen Inc.
• Aspen
• Elexis Inc.
• GlaxoSmithKline Plc
• GSK Plc
• IBSA Pharma（IBSA Group）
• Lannett Co. Inc.
• Merck KGaA
• Mylan N.V.
• Novartis AG
• Pfizer Inc.
• RLC Labs Inc.
• Sanofi
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

According to Stratistics MRC, the Global Thyroid Gland Disorders Treatment Market is accounted for $2726.85 million in 2022 and is expected to reach $3824.51 million by 2028 growing at a CAGR of 5.8% during the forecast period. A thyroid gland is an endocrine gland that promotes hormones that assist in controlling the body's metabolism. The body's metabolism and functionality are hampered when the thyroid gland produces too many or insufficient thyroid hormones. One of the main causes of thyroid diseases is a shortage of iodine in the body. More than 2 billion people are thought to be at risk of iodine deficiency globally, and half of those individuals are misdiagnosed. The majority of these individuals are undiagnosed, with the majority being in underdeveloped nations. Functional or structural problems can cause thyroid diseases. Women and the elderly are more likely to have this illness.

According to numbers published by the U.S. Department of Health and Human Services, around 1.2% people in the U.S. suffer from hypothyroidism each year. Moreover, women 2-10 times more susceptible than men to develop thyroid conditions.

Market Dynamics:

Driver:

Advancements in diagnostic and treatment technologies

There have been several advancements in diagnostic and treatment technologies in the Thyroid Gland Disorders Treatment Market, leading to improved patient outcomes and quality of life. In terms of diagnostic technologies, ultrasound is a non-invasive imaging technique that uses sound waves to create images of the thyroid gland. It is often used to detect thyroid nodules and can help determine whether a nodule is cancerous or benign. Fine-needle aspiration biopsy is another diagnostic technique that involves using a thin needle to extract cells from the thyroid gland for analysis. Advancements in diagnostic and treatment technologies have significantly improved the Thyroid Gland Disorders Treatment Market, leading to better patient outcomes and quality of life, which will accelerate market growth over the course of the forecast period.

Restraint:

Side effects and complications

Thyroid gland disorders can lead to several complications if left untreated or if treatment is not managed correctly. Treatment options for thyroid gland disorders vary depending on the specific type and severity of the disorder, but all treatments carry the risk of side effects and complications. While there are effective treatments available for thyroid gland disorders, all treatments carry the risk of side effects and complications. It is essential to work closely with a healthcare provider to manage treatment and monitor for any potential side effects or complications, which are projected to impede the fog computing market's growth.

Opportunity:

Growing prevalence of thyroid gland disorders

Thyroid gland disorders are increasingly prevalent worldwide, affecting millions of people. The prevalence of thyroid gland disorders is on the rise, and several factors contribute to this trend. Age is a significant factor, with the risk of developing a thyroid disorder increasing as one grows older. Women are also more likely to develop thyroid gland disorders than men. Environmental factors, such as exposure to radiation or certain chemicals, can increase the risk of developing a thyroid disorder. A family history of thyroid gland disorders also increases the risk of developing the condition.

Threat:

Stringent regulatory policies

The Thyroid Gland Disorders Treatment Market is subject to stringent regulatory policies to ensure the safety and efficacy of treatments. These policies are put in place by regulatory bodies such as the Food and Drug Administration (FDA) in the United States, the European Medicines Agency (EMA) in Europe, and other national regulatory agencies worldwide. Regulatory policies for thyroid gland disorders treatments include requirements for preclinical and clinical trials to establish the safety and efficacy of drugs, medical devices, and other treatments. These trials must adhere to strict guidelines for study design, patient recruitment, and ethical considerations. While stringent regulatory policies can create challenges for companies in the Thyroid Gland Disorders Treatment Market, they are essential to ensure the safety and efficacy of treatments for patients.

COVID-19 Impact:

Over the time frame of COVID, the majority of industries saw adverse effects. This can be attributed to the enormous disruptions that various precautionary lockdowns and other limitations that were imposed by governing agencies around the world caused in their respective production and supply-chain operations. The same is true for the global market for treatments for thyroid gland disorders. Additionally, consumer demand has now decreased as people have become more motivated to cut non-essential spending from their own budgets, as the general economic situation of the majority of people has been badly impacted by this outbreak.

The Hyperthyroidism segment is expected to be the largest during the forecast period

The overproduction of thyroxin by the thyroid gland results in hyperthyroidism. The category is anticipated to develop significantly over the projected period due to factors like the rising prevalence of thyroid cancer and hyperthyroidism around the world. Subclinical hyperthyroidism affects more women over 65 than males, according to a StatPearls article published in July 2022, whereas rates of overt hyperthyroidism are 0.4 per 1000 women and 0.1 per 1000 men and vary with age. The high prevalence of hyperthyroidism is anticipated to open up prospects for the creation of cutting-edge therapies for the condition, which is anticipated to fuel market expansion over the course of the projected period.

The levothyroxine segment is expected to have the highest CAGR during the forecast period

Throughout the projected period, levothyroxine will continue to see the highest CAGR for the treatment of hypothyroidism. The hypothyroidism and hyperthyroidism segments make up the majority of the market for drugs used to treat thyroid gland problems. Levothyroxine and liothyronine are examples of medications used to treat hypothyroidism. The market for the treatment of thyroid disorders is growing at a moderate rate, primarily as a result of the increased global prevalence of thyroid disorders, rising demand for levothyroxine-containing medications in both developing and developed regions, and ongoing efforts by top thyroid drug producers to create cutting-edge therapeutics.

Region with largest share:

Over the course of the anticipated period, North America accounted for the biggest revenue share. One reason for its high revenue share is the existence of efficient healthcare facilities, higher knowledge levels among people, and a wide range of available treatment alternatives. In the region, strategic alliances between pharmaceutical firms and governmental bodies are growing, especially to create generic medications and raise awareness among healthcare professionals. Because of this, the market in North America is quite profitable. For instance, Genzyme will offer tailored treatments for the management of thyroid gland problems in collaboration with Veracyte Inc.

Region with highest CAGR:

During the forecast period, Asia-Pacific is anticipated to have the fastest growth rate. Due to the increasing prevalence of thyroid disorders in the region and rising healthcare expenditure, as manufacturers in this region are focusing on the development of low-cost products with higher efficiency. In addition, global players are investing in local companies in the region, attracted by the lower cost of raw material and labor. Additionally, Thyroid Awareness Month was celebrated worldwide to raise awareness regarding thyroid-related diseases and thyroid cancer. Such initiatives are expected to boost early detection and treatment, which is expected to propel the market growth during the forecast period.

Key players in the market:

Some of the key players in Thyroid Gland Disorders Treatment Market include Abbott Laboratories, AbbVie Inc., ALLERGAN, Alvogen ehf, Amgen Inc., Aspen, Elexis Inc., GlaxoSmithKline Plc, GSK Plc, IBSA Pharma (IBSA Group), Lannett Co. Inc., Merck KGaA, Mylan N.V., Novartis AG, Pfizer Inc., RLC Labs Inc., Sanofi, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd. and Viatris Inc.

Key Developments:

In Nov 2022: Zydus Lifesciences, a US-based subsidiary, received approval from the USFDA to market Levothyroxine Sodium injection, used to treat thyroid hormone deficiency.

In May 2022: The United States Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) injection, Eli Lilly and Company's new once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.

In September 2021, Exelixis Inc. received USFDA approval for CABOMETYX (cabozantinib) for the treatment of adult and pediatric patients with locally advanced or metastatic differentiated thyroid cancer (DTC) that has progressed following prior vascular endothelial growth factor receptor (VEGFR)-targeted therapy and who are radioactive iodine-refractory or ineligible.

Type of Disorders Covered:

• Hypothyroidism
• Hyperthyroidism
• Other Types of Disorders

Route of Administrations Covered:

• Oral
• Parenteral
• Intravenous Route
• Other Routes of Administrations

Drug Classes Covered:

• Thioamides
• Ionic Inhibitors
• Hormone-release Inhibitors
• Other Drug Classes

Drug Types Covered:

• Levothyroxine
• Liothyronine
• Propylthiouracil
• Imidazole-Based Compounds
• Other Drug Types

Distribution Channels Covered:

• Wholesale Distribution
• Retail Stores
• Online Pharmacy
• Mail-Order Pharmacy
• Other Distribution Channels

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Emerging Markets
• 3.7 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Thyroid Gland Disorders Treatment Market, By Type of Disorder

• 5.1 Introduction
• 5.2 Hypothyroidism
• 5.3 Hyperthyroidism
• 5.4 Other Types of Disorders

6 Global Thyroid Gland Disorders Treatment Market, By Route of Administration

• 6.1 Introduction
• 6.2 Oral
• 6.3 Parenteral
• 6.4 Intravenous Route
• 6.5 Other Routes of Administrations

7 Global Thyroid Gland Disorders Treatment Market, By Drug Class

• 7.1 Introduction
• 7.2 Thioamides
• 7.3 Ionic Inhibitors
• 7.4 Hormone-release Inhibitors
• 7.5 Other Drug Classes

8 Global Thyroid Gland Disorders Treatment Market, By Drug Type

• 8.1 Introduction
• 8.2 Levothyroxine
• 8.3 Liothyronine
• 8.4 Propylthiouracil
• 8.5 Imidazole-Based Compounds
• 8.6 Other Drug Types

9 Global Thyroid Gland Disorders Treatment Market, By Distribution Channel

• 9.1 Introduction
• 9.2 Wholesale Distribution
• 9.3 Retail Stores
• 9.4 Online Pharmacy
• 9.5 Mail-Order Pharmacy
• 9.6 Other Distribution Channels

10 Global Thyroid Gland Disorders Treatment Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Abbott Laboratories
• 12.2 AbbVie Inc.
• 12.3 ALLERGAN
• 12.4 Alvogen ehf
• 12.5 Amgen Inc.
• 12.6 Aspen
• 12.7 Elexis Inc.
• 12.8 GlaxoSmithKline Plc
• 12.9 GSK Plc
• 12.10 IBSA Pharma (IBSA Group)
• 12.11 Lannett Co. Inc.
• 12.12 Merck KGaA
• 12.13 Mylan N.V.
• 12.14 Novartis AG
• 12.15 Pfizer Inc.
• 12.16 RLC Labs Inc.
• 12.17 Sanofi
• 12.18 Takeda Pharmaceutical Company Limited
• 12.19 Teva Pharmaceutical Industries Ltd.
• 12.20 Viatris Inc.

List of Tables

• Table 1 Global Thyroid Gland Disorders Treatment Market Outlook, By Region (2020-2028) ($MN)
• Table 2 Global Thyroid Gland Disorders Treatment Market Outlook, By Type of Disorder (2020-2028) ($MN)
• Table 3 Global Thyroid Gland Disorders Treatment Market Outlook, By Hypothyroidism (2020-2028) ($MN)
• Table 4 Global Thyroid Gland Disorders Treatment Market Outlook, By Hyperthyroidism (2020-2028) ($MN)
• Table 5 Global Thyroid Gland Disorders Treatment Market Outlook, By Other Types of Disorders (2020-2028) ($MN)
• Table 6 Global Thyroid Gland Disorders Treatment Market Outlook, By Route of Administration (2020-2028) ($MN)
• Table 7 Global Thyroid Gland Disorders Treatment Market Outlook, By Oral (2020-2028) ($MN)
• Table 8 Global Thyroid Gland Disorders Treatment Market Outlook, By Parenteral (2020-2028) ($MN)
• Table 9 Global Thyroid Gland Disorders Treatment Market Outlook, By Intravenous Route (2020-2028) ($MN)
• Table 10 Global Thyroid Gland Disorders Treatment Market Outlook, By Other Routes of Administrations (2020-2028) ($MN)
• Table 11 Global Thyroid Gland Disorders Treatment Market Outlook, By Drug Class (2020-2028) ($MN)
• Table 12 Global Thyroid Gland Disorders Treatment Market Outlook, By Thioamides (2020-2028) ($MN)
• Table 13 Global Thyroid Gland Disorders Treatment Market Outlook, By Ionic Inhibitors (2020-2028) ($MN)
• Table 14 Global Thyroid Gland Disorders Treatment Market Outlook, By Hormone-release Inhibitors (2020-2028) ($MN)
• Table 15 Global Thyroid Gland Disorders Treatment Market Outlook, By Other Drug Classes (2020-2028) ($MN)
• Table 16 Global Thyroid Gland Disorders Treatment Market Outlook, By Drug Type (2020-2028) ($MN)
• Table 17 Global Thyroid Gland Disorders Treatment Market Outlook, By Levothyroxine (2020-2028) ($MN)
• Table 18 Global Thyroid Gland Disorders Treatment Market Outlook, By Liothyronine (2020-2028) ($MN)
• Table 19 Global Thyroid Gland Disorders Treatment Market Outlook, By Propylthiouracil (2020-2028) ($MN)
• Table 20 Global Thyroid Gland Disorders Treatment Market Outlook, By Imidazole-Based Compounds (2020-2028) ($MN)
• Table 21 Global Thyroid Gland Disorders Treatment Market Outlook, By Other Drug Types (2020-2028) ($MN)
• Table 22 Global Thyroid Gland Disorders Treatment Market Outlook, By Distribution Channel (2020-2028) ($MN)
• Table 23 Global Thyroid Gland Disorders Treatment Market Outlook, By Wholesale Distribution (2020-2028) ($MN)
• Table 24 Global Thyroid Gland Disorders Treatment Market Outlook, By Retail Stores (2020-2028) ($MN)
• Table 25 Global Thyroid Gland Disorders Treatment Market Outlook, By Online Pharmacy (2020-2028) ($MN)
• Table 26 Global Thyroid Gland Disorders Treatment Market Outlook, By Mail-Order Pharmacy (2020-2028) ($MN)
• Table 27 Global Thyroid Gland Disorders Treatment Market Outlook, By Other Distribution Channels (2020-2028) ($MN)
• Table 28 North America Thyroid Gland Disorders Treatment Market Outlook, By Country (2020-2028) ($MN)
• Table 29 North America Thyroid Gland Disorders Treatment Market Outlook, By Type of Disorder (2020-2028) ($MN)
• Table 30 North America Thyroid Gland Disorders Treatment Market Outlook, By Hypothyroidism (2020-2028) ($MN)
• Table 31 North America Thyroid Gland Disorders Treatment Market Outlook, By Hyperthyroidism (2020-2028) ($MN)
• Table 32 North America Thyroid Gland Disorders Treatment Market Outlook, By Other Types of Disorders (2020-2028) ($MN)
• Table 33 North America Thyroid Gland Disorders Treatment Market Outlook, By Route of Administration (2020-2028) ($MN)
• Table 34 North America Thyroid Gland Disorders Treatment Market Outlook, By Oral (2020-2028) ($MN)
• Table 35 North America Thyroid Gland Disorders Treatment Market Outlook, By Parenteral (2020-2028) ($MN)
• Table 36 North America Thyroid Gland Disorders Treatment Market Outlook, By Intravenous Route (2020-2028) ($MN)
• Table 37 North America Thyroid Gland Disorders Treatment Market Outlook, By Other Routes of Administrations (2020-2028) ($MN)
• Table 38 North America Thyroid Gland Disorders Treatment Market Outlook, By Drug Class (2020-2028) ($MN)
• Table 39 North America Thyroid Gland Disorders Treatment Market Outlook, By Thioamides (2020-2028) ($MN)
• Table 40 North America Thyroid Gland Disorders Treatment Market Outlook, By Ionic Inhibitors (2020-2028) ($MN)
• Table 41 North America Thyroid Gland Disorders Treatment Market Outlook, By Hormone-release Inhibitors (2020-2028) ($MN)
• Table 42 North America Thyroid Gland Disorders Treatment Market Outlook, By Other Drug Classes (2020-2028) ($MN)
• Table 43 North America Thyroid Gland Disorders Treatment Market Outlook, By Drug Type (2020-2028) ($MN)
• Table 44 North America Thyroid Gland Disorders Treatment Market Outlook, By Levothyroxine (2020-2028) ($MN)
• Table 45 North America Thyroid Gland Disorders Treatment Market Outlook, By Liothyronine (2020-2028) ($MN)
• Table 46 North America Thyroid Gland Disorders Treatment Market Outlook, By Propylthiouracil (2020-2028) ($MN)
• Table 47 North America Thyroid Gland Disorders Treatment Market Outlook, By Imidazole-Based Compounds (2020-2028) ($MN)
• Table 48 North America Thyroid Gland Disorders Treatment Market Outlook, By Other Drug Types (2020-2028) ($MN)
• Table 49 North America Thyroid Gland Disorders Treatment Market Outlook, By Distribution Channel (2020-2028) ($MN)
• Table 50 North America Thyroid Gland Disorders Treatment Market Outlook, By Wholesale Distribution (2020-2028) ($MN)
• Table 51 North America Thyroid Gland Disorders Treatment Market Outlook, By Retail Stores (2020-2028) ($MN)
• Table 52 North America Thyroid Gland Disorders Treatment Market Outlook, By Online Pharmacy (2020-2028) ($MN)
• Table 53 North America Thyroid Gland Disorders Treatment Market Outlook, By Mail-Order Pharmacy (2020-2028) ($MN)
• Table 54 North America Thyroid Gland Disorders Treatment Market Outlook, By Other Distribution Channels (2020-2028) ($MN)
• Table 55 Europe Thyroid Gland Disorders Treatment Market Outlook, By Country (2020-2028) ($MN)
• Table 56 Europe Thyroid Gland Disorders Treatment Market Outlook, By Type of Disorder (2020-2028) ($MN)
• Table 57 Europe Thyroid Gland Disorders Treatment Market Outlook, By Hypothyroidism (2020-2028) ($MN)
• Table 58 Europe Thyroid Gland Disorders Treatment Market Outlook, By Hyperthyroidism (2020-2028) ($MN)
• Table 59 Europe Thyroid Gland Disorders Treatment Market Outlook, By Other Types of Disorders (2020-2028) ($MN)
• Table 60 Europe Thyroid Gland Disorders Treatment Market Outlook, By Route of Administration (2020-2028) ($MN)
• Table 61 Europe Thyroid Gland Disorders Treatment Market Outlook, By Oral (2020-2028) ($MN)
• Table 62 Europe Thyroid Gland Disorders Treatment Market Outlook, By Parenteral (2020-2028) ($MN)
• Table 63 Europe Thyroid Gland Disorders Treatment Market Outlook, By Intravenous Route (2020-2028) ($MN)
• Table 64 Europe Thyroid Gland Disorders Treatment Market Outlook, By Other Routes of Administrations (2020-2028) ($MN)
• Table 65 Europe Thyroid Gland Disorders Treatment Market Outlook, By Drug Class (2020-2028) ($MN)
• Table 66 Europe Thyroid Gland Disorders Treatment Market Outlook, By Thioamides (2020-2028) ($MN)
• Table 67 Europe Thyroid Gland Disorders Treatment Market Outlook, By Ionic Inhibitors (2020-2028) ($MN)
• Table 68 Europe Thyroid Gland Disorders Treatment Market Outlook, By Hormone-release Inhibitors (2020-2028) ($MN)
• Table 69 Europe Thyroid Gland Disorders Treatment Market Outlook, By Other Drug Classes (2020-2028) ($MN)
• Table 70 Europe Thyroid Gland Disorders Treatment Market Outlook, By Drug Type (2020-2028) ($MN)
• Table 71 Europe Thyroid Gland Disorders Treatment Market Outlook, By Levothyroxine (2020-2028) ($MN)
• Table 72 Europe Thyroid Gland Disorders Treatment Market Outlook, By Liothyronine (2020-2028) ($MN)
• Table 73 Europe Thyroid Gland Disorders Treatment Market Outlook, By Propylthiouracil (2020-2028) ($MN)
• Table 74 Europe Thyroid Gland Disorders Treatment Market Outlook, By Imidazole-Based Compounds (2020-2028) ($MN)
• Table 75 Europe Thyroid Gland Disorders Treatment Market Outlook, By Other Drug Types (2020-2028) ($MN)
• Table 76 Europe Thyroid Gland Disorders Treatment Market Outlook, By Distribution Channel (2020-2028) ($MN)
• Table 77 Europe Thyroid Gland Disorders Treatment Market Outlook, By Wholesale Distribution (2020-2028) ($MN)
• Table 78 Europe Thyroid Gland Disorders Treatment Market Outlook, By Retail Stores (2020-2028) ($MN)
• Table 79 Europe Thyroid Gland Disorders Treatment Market Outlook, By Online Pharmacy (2020-2028) ($MN)
• Table 80 Europe Thyroid Gland Disorders Treatment Market Outlook, By Mail-Order Pharmacy (2020-2028) ($MN)
• Table 81 Europe Thyroid Gland Disorders Treatment Market Outlook, By Other Distribution Channels (2020-2028) ($MN)
• Table 82 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Country (2020-2028) ($MN)
• Table 83 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Type of Disorder (2020-2028) ($MN)
• Table 84 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Hypothyroidism (2020-2028) ($MN)
• Table 85 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Hyperthyroidism (2020-2028) ($MN)
• Table 86 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Other Types of Disorders (2020-2028) ($MN)
• Table 87 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Route of Administration (2020-2028) ($MN)
• Table 88 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Oral (2020-2028) ($MN)
• Table 89 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Parenteral (2020-2028) ($MN)
• Table 90 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Intravenous Route (2020-2028) ($MN)
• Table 91 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Other Routes of Administrations (2020-2028) ($MN)
• Table 92 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Drug Class (2020-2028) ($MN)
• Table 93 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Thioamides (2020-2028) ($MN)
• Table 94 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Ionic Inhibitors (2020-2028) ($MN)
• Table 95 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Hormone-release Inhibitors (2020-2028) ($MN)
• Table 96 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Other Drug Classes (2020-2028) ($MN)
• Table 97 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Drug Type (2020-2028) ($MN)
• Table 98 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Levothyroxine (2020-2028) ($MN)
• Table 99 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Liothyronine (2020-2028) ($MN)
• Table 100 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Propylthiouracil (2020-2028) ($MN)
• Table 101 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Imidazole-Based Compounds (2020-2028) ($MN)
• Table 102 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Other Drug Types (2020-2028) ($MN)
• Table 103 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Distribution Channel (2020-2028) ($MN)
• Table 104 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Wholesale Distribution (2020-2028) ($MN)
• Table 105 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Retail Stores (2020-2028) ($MN)
• Table 106 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Online Pharmacy (2020-2028) ($MN)
• Table 107 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Mail-Order Pharmacy (2020-2028) ($MN)
• Table 108 Asia Pacific Thyroid Gland Disorders Treatment Market Outlook, By Other Distribution Channels (2020-2028) ($MN)
• Table 109 South America Thyroid Gland Disorders Treatment Market Outlook, By Country (2020-2028) ($MN)
• Table 110 South America Thyroid Gland Disorders Treatment Market Outlook, By Type of Disorder (2020-2028) ($MN)
• Table 111 South America Thyroid Gland Disorders Treatment Market Outlook, By Hypothyroidism (2020-2028) ($MN)
• Table 112 South America Thyroid Gland Disorders Treatment Market Outlook, By Hyperthyroidism (2020-2028) ($MN)
• Table 113 South America Thyroid Gland Disorders Treatment Market Outlook, By Other Types of Disorders (2020-2028) ($MN)
• Table 114 South America Thyroid Gland Disorders Treatment Market Outlook, By Route of Administration (2020-2028) ($MN)
• Table 115 South America Thyroid Gland Disorders Treatment Market Outlook, By Oral (2020-2028) ($MN)
• Table 116 South America Thyroid Gland Disorders Treatment Market Outlook, By Parenteral (2020-2028) ($MN)
• Table 117 South America Thyroid Gland Disorders Treatment Market Outlook, By Intravenous Route (2020-2028) ($MN)
• Table 118 South America Thyroid Gland Disorders Treatment Market Outlook, By Other Routes of Administrations (2020-2028) ($MN)
• Table 119 South America Thyroid Gland Disorders Treatment Market Outlook, By Drug Class (2020-2028) ($MN)
• Table 120 South America Thyroid Gland Disorders Treatment Market Outlook, By Thioamides (2020-2028) ($MN)
• Table 121 South America Thyroid Gland Disorders Treatment Market Outlook, By Ionic Inhibitors (2020-2028) ($MN)
• Table 122 South America Thyroid Gland Disorders Treatment Market Outlook, By Hormone-release Inhibitors (2020-2028) ($MN)
• Table 123 South America Thyroid Gland Disorders Treatment Market Outlook, By Other Drug Classes (2020-2028) ($MN)
• Table 124 South America Thyroid Gland Disorders Treatment Market Outlook, By Drug Type (2020-2028) ($MN)
• Table 125 South America Thyroid Gland Disorders Treatment Market Outlook, By Levothyroxine (2020-2028) ($MN)
• Table 126 South America Thyroid Gland Disorders Treatment Market Outlook, By Liothyronine (2020-2028) ($MN)
• Table 127 South America Thyroid Gland Disorders Treatment Market Outlook, By Propylthiouracil (2020-2028) ($MN)
• Table 128 South America Thyroid Gland Disorders Treatment Market Outlook, By Imidazole-Based Compounds (2020-2028) ($MN)
• Table 129 South America Thyroid Gland Disorders Treatment Market Outlook, By Other Drug Types (2020-2028) ($MN)
• Table 130 South America Thyroid Gland Disorders Treatment Market Outlook, By Distribution Channel (2020-2028) ($MN)
• Table 131 South America Thyroid Gland Disorders Treatment Market Outlook, By Wholesale Distribution (2020-2028) ($MN)
• Table 132 South America Thyroid Gland Disorders Treatment Market Outlook, By Retail Stores (2020-2028) ($MN)
• Table 133 South America Thyroid Gland Disorders Treatment Market Outlook, By Online Pharmacy (2020-2028) ($MN)
• Table 134 South America Thyroid Gland Disorders Treatment Market Outlook, By Mail-Order Pharmacy (2020-2028) ($MN)
• Table 135 South America Thyroid Gland Disorders Treatment Market Outlook, By Other Distribution Channels (2020-2028) ($MN)
• Table 136 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Country (2020-2028) ($MN)
• Table 137 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Type of Disorder (2020-2028) ($MN)
• Table 138 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Hypothyroidism (2020-2028) ($MN)
• Table 139 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Hyperthyroidism (2020-2028) ($MN)
• Table 140 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Other Types of Disorders (2020-2028) ($MN)
• Table 141 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Route of Administration (2020-2028) ($MN)
• Table 142 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Oral (2020-2028) ($MN)
• Table 143 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Parenteral (2020-2028) ($MN)
• Table 144 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Intravenous Route (2020-2028) ($MN)
• Table 145 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Other Routes of Administrations (2020-2028) ($MN)
• Table 146 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Drug Class (2020-2028) ($MN)
• Table 147 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Thioamides (2020-2028) ($MN)
• Table 148 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Ionic Inhibitors (2020-2028) ($MN)
• Table 149 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Hormone-release Inhibitors (2020-2028) ($MN)
• Table 150 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Other Drug Classes (2020-2028) ($MN)
• Table 151 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Drug Type (2020-2028) ($MN)
• Table 152 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Levothyroxine (2020-2028) ($MN)
• Table 153 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Liothyronine (2020-2028) ($MN)
• Table 154 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Propylthiouracil (2020-2028) ($MN)
• Table 155 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Imidazole-Based Compounds (2020-2028) ($MN)
• Table 156 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Other Drug Types (2020-2028) ($MN)
• Table 157 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Distribution Channel (2020-2028) ($MN)
• Table 158 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Wholesale Distribution (2020-2028) ($MN)
• Table 159 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Retail Stores (2020-2028) ($MN)
• Table 160 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Online Pharmacy (2020-2028) ($MN)
• Table 161 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Mail-Order Pharmacy (2020-2028) ($MN)
• Table 162 Middle East & Africa Thyroid Gland Disorders Treatment Market Outlook, By Other Distribution Channels (2020-2028) ($MN)